Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Berruezo Llacuna, Maria (1) Di Virgilio, Michela Prof. Dr. (1) Driesner, Madlen (1) Filosa, Alessandro Dr. (1) Graf, Robin Dr. (2) Höpken, Uta Elisabeth PD Dr. (1) Jeuthe, Sarah Dr. (1) Kammertöns, Thomas Dr. (6) Keller, Lisa (1) Keller, Ulrich Dr. med. (2) Kieback, Elisa Dr. (1) Kocks, Christine Dr. (1) Kopp, Joachim Dr. (1) Leutz, Achim Prof. Dr. (2) Mathas, Stephan Dr. (8) Mertins, Philipp Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Popp, Oliver Dr. (1) Prigione, Alessandro Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Sawamiphak, Suphansa Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (4) Willimsky, Gerald Dr. (6) (-) Blankenstein, Thomas Prof. Dr. (15) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (8) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) Bioinformatics and Omics Data Science (1) (-) Biologie maligner Lymphome (8) Genomdiversifikation & Integrität (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) (-) Molekulare Immunologie und Gentherapie (16) Proteom Dynamik (13) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) RNA Biologie und Posttranscriptionale Regulation (1) Systembiologie von Gen-regulatorischen Elementen (1) Translationale Onkologie solider Tumore (1) Translationale Tumorimmunologie (2) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (3) 2000 (9) 2001 (5) 2002 (6) 2003 (12) 2004 (10) (-) 2005 (12) 2006 (5) 2007 (7) (-) 2008 (7) 2009 (5) 2010 (8) 2011 (9) 2012 (8) 2013 (13) 2014 (4) 2015 (6) 2016 (5) 2017 (9) 2018 (5) 2019 (7) (-) 2020 (5) 2021 (7) 2022 (10) 2023 (10) 2024 (3) 24 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Prof. Dr. rer. nat.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 200520082020 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 20. Mai 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein 01. Januar 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel 01. Januar 2005 / Int J Cancer Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells L. Staerck C. Scholz T. Blankenstein B. Doerken P.T. Daniel 01. Januar 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein 01. Januar 2005 / Trends Mol Med Immunotherapy: target the stroma to hit the tumor T. Kammertoens T. Schueler T. Blankenstein 08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov 07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein 01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein 15. Oktober 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas 01. September 2008 / Haematologica The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells? M. Janz S. Mathas Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
20. Mai 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein
01. Januar 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel
01. Januar 2005 / Int J Cancer Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells L. Staerck C. Scholz T. Blankenstein B. Doerken P.T. Daniel
01. Januar 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein
01. Januar 2005 / Trends Mol Med Immunotherapy: target the stroma to hit the tumor T. Kammertoens T. Schueler T. Blankenstein
08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov
07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
15. Oktober 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas
01. September 2008 / Haematologica The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells? M. Janz S. Mathas